Phyla, founded with a mission to provide intestinal peace of mind, is a digital health provider specializing in at-home gut health testing and personalized diet advice. The company offers a mobile app that allows users to monitor their diet, symptoms, and lifestyle, while also facilitating the discovery of the microbiome through convenient at-home stool testing. Phyla primarily focuses on aiding individuals with IBD (Inflammatory Bowel Disease) and IBS (Irritable Bowel Syndrome) by helping them understand the relationship between their diet, lifestyle, and symptoms.

Notable affiliated people and investors are not specified, but Phyla's key achievements include the development of a comprehensive digital platform that integrates gut health monitoring with personalized dietary recommendations. The overall impact of Phyla has been significant in empowering individuals to take control of their gut health, thereby improving their quality of life through informed dietary and lifestyle choices.